Skip to main content

Table 5 Receiver operating characteristic curve of LV function and deformation in OCAD patients

From: The additive effect of metabolic syndrome on left ventricular impairment in patients with obstructive coronary artery disease assessed by 3.0 T cardiac magnetic resonance feature tracking

 

GLPS

LVM

AUC% (95% CI)

Sensitivity%

Specificity%

PPV%

NPV%

AUC% (95% CI)

Sensitivity%

Specificity%

PPV%

NPV%

MetS

0.62 (0.52–0.72)

80.0

43.3

58.5

68.4

0.67 (0.57–0.76)

85.0

48.3

62.1

76.3

NT-proBNPa (pg/mL)

0.83 (0.76–0.91)

71.7

73.3

72.8

72.1

0.70 (0.60–0.80)

65.0

66.7

66.1

65.5

Smoking

0.63 (0.53–0.73)

65.0

61.7

62.9

63.7

0.68 (0.59–0.78)

70.0

66.7

67.7

68.9

Gensini score

0.61 (0.50–0.71)

51.7

66.7

60.7

57.9

Gender (male, n)

0.68 (0.58–0.77)

96.7

38.3

61.0

80.0

Logistic regression modelb

0.88 (0.83–0.94)

81.7

78.3

79.0

81.0

0.89 (0.83–0.94)

85.0

80.0

80.9

84.2

  1. LVM left ventricular mass, GLPS global longitudinal peak strain, AUC area under curve, MetS metabolic syndrome, NT-proBNP amino-terminal pro-B-type natriuretic peptide, PPV positive predictive value, NPV negative predictive value
  2. aNT-proBNP was log-transformed before being included in the regression analysis
  3. bThe model combined MetS, NT-proBNP, smoking, and Gensini score in GLPS; the model combined MetS, NT-proBNP, smoking, and Gender (male) in LVM